Comments on ‘Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer’

Xinyuan Tong¹ , Ningxia Zhang² , Yun Xue^1,3 , Hongbin Ji^1,3,4,*

¹Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China
²Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China
³School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China
⁴School of Life Science and Technology, ShanghaiTech University, Shanghai 200120, China
^*Correspondence to:Hongbin Ji , Email:hbji@sibcb.ac.cn

J Mol Cell Biol, Volume 16, Issue 3, March 2024, mjae013,  https://doi.org/10.1093/jmcb/mjae013

• Abstract
• Full Text

---